Removing treatment barriers and burden helps to set patients up for success in a way that meets their lifestyle, helping them achieve their treatment goals. Help is now at hand.
Click here for V-Go® free trial
Innovation in dose delivery has been associated with improved patient compliance.
Diabetes is the fastest growing health crisis in New Zealand, with over 240,000 patients registered and approximately 41,000 using insulin. The emotional and social burden associated with insulin treatment cannot be ignored as it can greatly affect patients’ compliance, and therefore treatment success, which can reflect poorly on patients’ morale. 1,2,3,4
Insulin as a treatment option for type 2 diabetes is often prescribed as a last resort. This can result in a stigma around insulin treatment. Patients can often feel like they have failed all other treatment options presented to them.
With the launch of V-Go® in NZ, this has all changed. V-Go® is a new all-in-one disposable basal-bolus insulin delivery device for patients with type 2 diabetes. V-Go® is worn like a patch on the abdomen, arm, back or thigh5 and removes the need for multiple daily injections.
V-Go® relieves the need to carry needle or syringes. The needle is never exposed or seen by the patients, which makes it the ideal treatment option for patients with needle phobia.
The convenience and flexibility of the system enables you, as healthcare professionals, to remove treatment barriers and psychosocial burden.